ciprofloxacin and colistin

ciprofloxacin has been researched along with colistin in 102 studies

Research

Studies (102)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (5.88)	18.7374
1990's	10 (9.80)	18.2507
2000's	16 (15.69)	29.6817
2010's	36 (35.29)	24.3611
2020's	34 (33.33)	2.80

Authors

Authors	Studies
Daenen, S; Donnelly, JP; Maschmeyer, G	1
Høiby, N; Koch, C; Valerius, NH	1
Daenen, S; de Pauw, BE; de Vries-Hospers, HG; Dekker, AW; Donnelly, JP; Gaus, W; Haralambie, E; Kern, W; Konrad, H; Maschmeyer, G	1
Arning, M; Aul, C; Heyll, A; Scharf, RE; Scheider, W; Wolf, HH	1
Allerberger, F; Dierich, MP	1
Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ	1
Dekker, A; Rozenberg-Arska, M; Verhoef, J	1
Kibbler, CC; Mannan, P; Noone, P	1
Dekker, AW; Rozenberg-Arska, M	1
Dekker, AW; Rozenberg-Arska, M; Verhoef, J	1
Hambleton, G; Hung, JC; Super, M	1
Corera, M; Gaztelurrutia, L; Municio, M; Sojo, A; Vazquez, C; Vitoria, JC	1
Benzer, H; Berger, J; Javorsky, F; Lejeune, P; Lingnau, W; Mutz, N	1
Cohen, M; Morlin, G; Ramsey, B; Smith, A; Weber, A; Williams-Warren, J	1
Frederiksen, B; Høiby, N; Koch, C	1
Andremont, A; Chachaty, E; Couvreur, P; Page-Clisson, ME; Pinto-Alphandary, H	1
Bhamra, A; Hann, IM; Kibbler, CC; Nazareth, B; Paterson, P; Prentice, HG	1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E	1
Assael, BM; Candusso, M; Faraguna, D; Marchetti, F	1
Griese, M; Müller, I; Reinhardt, D	1
Pitt, TL; Sparrow, M; Stefanidou, M; Warner, M	1
Gøtzsche, PC; Høiby, N; Johansen, HK; Koch, C; Nørregaard, L; Pressler, T	1
Frederiksen, B; Høiby, N; Pressler, T	1
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A	1
Beno, P; Demitrovicova, A; Krcmery, V	1
Appelbaum, PC; Lin, G; Pankuch, GA; Seifert, H	1
Folkesson, A; Haagensen, JA; Molin, S; Sternberg, C; Zampaloni, C	1
Hansen, CR; Høiby, N; Pressler, T	1
Bertram, C; Elborn, JS; Hodson, M	1
Boni, V; Braccini, G; Braggion, C; Campana, S; Festini, F; Galici, V; Neri, AS; Taccetti, G; Trevisan, F; Zavataro, L	1
Blázquez, J; López, E	1
Cho, JH; Jeong, SH; Song, YK	1
Gierczyński, R; Jagielski, M; Piekarska, K; Szych, J; Wardak, S; Wilk, E; Zacharczuk, K; Zawidzka, E	1
Barbier, F; Wolff, M	1
Cho, E; Davidson, AG; Lillquist, YP	1
Hendrich, AB; Janeczko, N; Kicia, M; Lewicka, J	1
Bozkurt-Guzel, C; Gerceker, AA; Savage, PB	1
Bianchini, E; Buzzetti, R; Campana, S; Cariani, L; Costantini, D; Taccetti, G; Trevisan, F; Zavataro, L	1
Dimopoulou, D; Falagas, ME; Karageorgopoulos, DE; Kofteridis, DP; Levis, P; Maraki, S; Samonis, G; Spernovasilis, NA	1
Boulanger, L; De Boeck, K; Proesmans, M; Verhaegen, J; Vermeulen, F	1
Hermann, B; Keller, PM; Klinger, M; Makarewicz, O; Nietzsche, S; Pfister, W; Sachse, S; Sobke, A; Straube, E	1
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T	1
Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH	1
D'Souza, BB; Padmaraj, SR; Pothen, P; Prabhu, S; Rekha, PD; Tellis, RC	1
Buyck, JM; Tulkens, PM; Van Bambeke, F	1
Langton Hewer, SC; Smyth, AR	2
Bekeredjian-Ding, I; Brossart, P; Felder, L; Hahn-Ast, C; Krause, S; Mayer, K; Molitor, E; Mückter, S; Schmitz, A; von Lilienfeld-Toal, M	1
Ali, H; Alshafi, K; Bilton, D; Mariveles, M; Orchard, C; Scott, S; Simmonds, N	1
Aranda, J; Barbé, J; Bou, G; Cortés, P; Jara, LM	1
Blaskovich, MA; Butler, MS; Cooper, MA; Elliott, AG; Huang, JX; Kavanagh, A; Montgomery, AB; Pelingon, R; Ramu, S	1
Fernandes, M; Kumar, N; Medikonda, R; Vira, D	1
Jagannadham, MV; Kulkarni, HM; Nagaraj, R	1
Baziard, G; El Hage, S; Furiga, A; Lajoie, B; Roques, C	1
Ciofu, O; Hengzhuang, W; Høiby, N; Onsøyen, E; Rye, PD; Song, Z	1
Becker, K; Berdel, WE; Büchner, T; Gerth, HU; Görlich, D; Karch, H; Krug, U; Lenz, G; Marx, J; Mellmann, A; Mesters, RM; Mikesch, JH; Müller-Tidow, C; Peters, G; Pohlen, M; Schliemann, C; Stelljes, M	1
Browatzki, A; Fjaellegaard, K; Sin, MD; Ulrik, CS	1
Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM	1
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A	1
Audisio, E; Bianco, G; Boattini, M; Cavallo, R; Costa, C	1
Ahn, P; Bhujbal, S; Cavallaro, A; Li, J; Mangal, S; Park, H; Shetty, N; Zemlyanov, D; Zhou, QT	1
Chai, G; Li, J; Lin, Y; Ling, J; Shetty, N; Wang, S; Wickremasinghe, H; Yu, HH; Yu, S; Zhou, QT; Zou, P	1
Bousquet, E; Mascaron, L; Szuster-Ciesielska, A; Urban-Chmiel, R; Wasak, M; Wernicki, A	1
Britton, WJ; Chan, HK; Chang, RYK; Kutter, E; Lin, Y; Morales, S	1
Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S	1
Cilleruelo Ortega, MJ; Eugenieva Marinova, F; Golmayo Gaztelu, L; Orden Martínez, B; Rasines Rodríguez, A; Saez Nieto, JA; Villaverde González, S	1
Cavallaro, A; Ling, J; Mangal, S; Park, H; Wang, S; Zhou, QT	1
Boulanger, B; Cizeau, F; Decousser, JW; Ducellier, D; Fourreau, F; Mercier-Darty, M; Mongardon, N; Podglajen, I; Potron, A; Royer, G	1
Chai, G; Li, J; Park, H; Xu, Q; Yu, S; Zhou, F; Zhou, QT	1
Abdi, SN; Asgharzadeh, M; Baghi, HB; Bastami, M; Ganbarov, K; Gholizadeh, P; Ghotaslou, R; Hasani, A; Mehramouz, B; Narenji, H; Samadi Kafil, H; Tanomand, A; Yousefi, B; Yousefi, M	1
Chai, G; Li, J; Lin, YW; Pan, W; Velkov, T; Wang, S; Yu, S; Zhou, QT; Zou, P	1
Baek, MS; Chung, ES; Jung, DS; Ko, KS	1
Antonelli, A; Cantón, R; Coppi, M; de Vogel, C; Gijón, D; Giske, CG; Hasan, B; Maruri, A; Rossolini, GM; Tellapragada, C; van Wamel, W; Verbon, A	1
Ariza, J; Benavent, E; Cabo, X; Gómez-Junyent, J; Murillo, O; Padullés, A; Rigo-Bonnin, R; Soldevila, L; Tubau, F	1
Chai, G; Chan, HK; Li, J; Li, X; Peng, K; Yu, S; Yuan, H; Zhou, F; Zhou, QT; Zou, P	1
Archetti, M; Baumgartner, M; Kümmerli, R; Mignot, I; Rezzoagli, C	1
Lee, J; Lee, JH; Raorane, CJ	1
Fukuda, A; Hirai, Y; Nakamura, H; Ogasawara, J; Umeda, K; Usui, M; Yamamoto, K	1
Anders Juul Haagensen, J; Birk, SE; Boisen, A; Borre Hansen, M; Hagner Nielsen, L; Krogh Johansen, H; Mazzoni, C; Mobasharah Javed, M; Molin, S	1
Chomnawang, MT; Houngsaitong, J; Kanathum, P; Khuntayaporn, P; Montakantikul, P; Thirapanmethee, K	1
Ari, MM; Jazi, FM; Kalani, BS; Razavi, S; Talebi, M; Zadeh, RG	1
Hochvaldová, L; Kohlová, V; Kolář, M; Kvítek, L; Panáček, A; Panáček, D; Prucek, R; Válková, L; Večeřová, R	1
Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S	1
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D	1
Alexander, J; Holger, DJ; Kebriaei, R; Lehman, SM; Lev, KL; Morrisette, T; Rybak, MJ; Shah, R	1
Abel, NS; Atri, B; Bourquard, T; Bowling, EA; Chen, TJ; Herman, C; Hsu, TK; Katsonis, P; Lichtarge, O; Lurie, PD; Marciano, DC; Nehring, RB; Rosenberg, SM; Wang, C	1
Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN	1
Barati, M; Golmoradi Zadeh, R; Masjedian Jazi, F; Mirshekar, M; Pourghader, J; Sadeghi Kalani, B	1
Aktas, Z; Basaran, S; Cagatay, A; Copur, B; Dosler, S; Eraksoy, H; Oncul, O; Ozsut, H; Simsek-Yavuz, S	1
Abulaila, A; Aktas, Z; Cantón, R; Díez-Aguilar, M; Erdem, F; Kayacan, C; Morosini, MI; Oksuz, L; Oncul, O	1
Alves, D; Lopes, H; Machado, I; Pereira, MO	1
Hayashi, C; Kai, D; Kamoshida, G; Kanda, N; Kaya, Y; Morimoto, H; Nakamura, T; Okada, T; Sakaguchi, M; Sawada, T; Takemoto, N; Yahiro, K; Yamada, N; Yamaguchi, D; Yamashita, M	1
Ghafar, NA; Hamid, AA; Ismail, R; Sulayyim, HJA	1
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z	1
Adeniji, OO; Elsheikh, EAE; Okoh, AI	1
Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM	1
Friman, VP; Law, JP; Wood, AJ	1
Li, Y; Morgan, H; Spencer, D; Sutton, JM; Zhu, Y	1
Alisoltani, A; Atassi, G; Hauser, AR; Medernach, R; Murphy, KR; Murphy-Belcaster, M; Nozick, S; Ozer, EA; Rhodes, NJ; Scheetz, M	1
Langton Hewer, SC; Rowbotham, NJ; Smith, S; Smyth, AR; Yule, A	1
Qiu, S; Xiang, Y; Yang, C	1
Chatupheeraphat, C; Eiamphungporn, W; Luk-In, S; Peamchai, J; Yainoy, S	1

Reviews

10 review(s) available for ciprofloxacin and colistin

Article	Year
Prevention of infection in acute leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; Infection Control; Infections; Leukemia; Multicenter Studies as Topic; Neutropenia; Norfloxacin; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination	1990
Eradication of early Pseudomonas aeruginosa infection. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4 Suppl 2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Colistin; Cystic Fibrosis; Denmark; Humans; Incidence; Pseudomonas Infections	2005
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2005
[Multi-drug resistant Pseudomonas aeruginosa: towards a therapeutic dead end?]. Medecine sciences : M/S, 2010, Volume: 26, Issue:11 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cross Infection; Drug Resistance, Multiple; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. The Cochrane database of systematic reviews, 2014, Nov-10, Issue:11 Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin	2014
Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review. Chronic respiratory disease, 2017, Volume: 14, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bronchiectasis; Ciprofloxacin; Colistin; Disease Progression; Forced Expiratory Volume; Humans; Macrolides; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Sputum	2017
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. The Cochrane database of systematic reviews, 2017, 04-25, Volume: 4 Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory System; Tobramycin	2017
Antibiotic Resistance during COVID-19: A Systematic Review. International journal of environmental research and public health, 2022, 09-21, Volume: 19, Issue:19 Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Colistin; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Humans; Microbial Sensitivity Tests; Pandemics; Pseudomonas aeruginosa	2022
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. The Cochrane database of systematic reviews, 2023, 06-02, Volume: 6 Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Infant; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2023
Resistance in Enteric Shigella and nontyphoidal Salmonella : emerging concepts. Current opinion in infectious diseases, 2023, 10-01, Volume: 36, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Colistin; Humans; Salmonella; Shigella	2023

Trials

14 trial(s) available for ciprofloxacin and colistin

Article	Year
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5 Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination	1992
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (London, England), 1991, Sep-21, Volume: 338, Issue:8769 Topics: Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	1991
Prevention of infection in acute leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; Infection Control; Infections; Leukemia; Multicenter Studies as Topic; Neutropenia; Norfloxacin; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination	1990
Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl D Topics: Bacterial Infections; Ciprofloxacin; Colistin; Humans; Neutropenia; Ofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination	1990
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens. Haematology and blood transfusion, 1987, Volume: 30 Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Infection Control; Leukemia; Neomycin; Neutropenia; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1987
Ciprofloxacin for infection prevention in patients with acute leukemia. Pharmaceutisch weekblad. Scientific edition, 1987, Dec-11, Volume: 9 Suppl Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Leukemia; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1987
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of internal medicine, 1987, Volume: 106, Issue:1 Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Microbial; Humans; Leukemia; Leukemia, Lymphoid; Patient Compliance; Random Allocation; Sulfamethizole; Sulfathiazoles; Trimethoprim	1987
Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Acta paediatrica (Oslo, Norway : 1992), 1993, Volume: 82, Issue:3 Topics: Adolescent; Aerosols; Bronchial Diseases; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Time Factors	1993
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. The Journal of trauma, 1997, Volume: 42, Issue:4 Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Translocation; Ciprofloxacin; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intestines; Male; Multiple Trauma; Pneumonia; Prospective Studies; Respiration, Artificial; Tobramycin	1997
Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatric pulmonology, 1997, Volume: 23, Issue:5 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Carrier State; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Lung Diseases; Male; Proportional Hazards Models; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric; Vital Capacity	1997
Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance. British journal of haematology, 2001, Volume: 115, Issue:1 Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; Middle Aged; Neomycin; Neutropenia; Statistics, Nonparametric; Transplantation Conditioning; Treatment Outcome	2001
Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis. European journal of medical research, 2002, Feb-21, Volume: 7, Issue:2 Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Case-Control Studies; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2002
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax, 2012, Volume: 67, Issue:10 Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin; Treatment Outcome	2012
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:1 Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Prospective Studies; Pseudomonas Infections; Sputum; Tobramycin; Treatment Outcome	2013

Other Studies

79 other study(ies) available for ciprofloxacin and colistin

Article	Year
[Mechanisms of action of chemotherapeutic drugs--microcalorimetric studies]. Wiener klinische Wochenschrift, 1989, Mar-31, Volume: 101, Issue:7 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Calorimetry; Calorimetry, Differential Scanning; Ciprofloxacin; Colistin; Disinfectants; Dose-Response Relationship, Drug; Energy Metabolism; Escherichia coli; Imipenem; Phenol; Phenols; Polymyxin B	1989
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal. Scandinavian journal of infectious diseases, 1985, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin	1985
Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:6 Topics: Agranulocytosis; Ciprofloxacin; Colistin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections	1988
Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics. Archives of disease in childhood, 1994, Volume: 71, Issue:4 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Gentamicins; Humans; Nebulizers and Vaporizers; Osmolar Concentration; Time Factors	1994
Effect of nebulizer type and antibiotic concentration on device performance. Pediatric pulmonology, 1997, Volume: 23, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Equipment Design; Humans; Hydrogen-Ion Concentration; Nebulizers and Vaporizers; Osmolar Concentration; Particle Size; Viscosity	1997
Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella. Pharmaceutical research, 1998, Volume: 15, Issue:4 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Colistin; Cyanoacrylates; Drug Carriers; Female; Liver; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Particle Size; Salmonella Infections, Animal; Salmonella typhimurium; Spleen	1998
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins	2001
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients. Lancet (London, England), 2002, Feb-16, Volume: 359, Issue:9306 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Ciprofloxacin; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Humans; Pseudomonas Infections; Tobramycin	2002
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax, 2003, Volume: 58, Issue:9 Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2003
Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatric pulmonology, 2004, Volume: 37, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Child; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Deoxyribonuclease I; Humans; Immunoelectrophoresis, Two-Dimensional; Linear Models; Pseudomonas Infections; Survival Analysis; Time Factors	2004
Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Neoplasms	2006
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	2008
Biofilm induced tolerance towards antimicrobial peptides. PloS one, 2008, Apr-02, Volume: 3, Issue:4 Topics: Antimicrobial Cationic Peptides; Biofilms; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Tolerance; Escherichia coli; Flow Cytometry; Fluoroquinolones; Microbial Sensitivity Tests; Microscopy, Confocal; Mutation; Plasmids	2008
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:6 Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Female; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome; Young Adult	2008
Implementation of European standards of care for cystic fibrosis--control and treatment of infection. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2009, Volume: 8, Issue:3 Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Burkholderia Infections; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Europe; Guideline Adherence; Humans; Infection Control; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Surveys and Questionnaires; Tobramycin; Young Adult	2009
The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child, Preschool; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Colistin; Cost of Illness; Cystic Fibrosis; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins; Ticarcillin; Tobramycin	2009
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim	2009
Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota. Regulatory toxicology and pharmacology : RTP, 2009, Volume: 53, Issue:3 Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bambermycins; Ciprofloxacin; Colistin; Feces; Female; Humans; Intestines; Microbial Sensitivity Tests; No-Observed-Adverse-Effect Level; Quinoxalines; Risk Assessment; Veterinary Drugs; Young Adult	2009
[Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland]. Medycyna doswiadczalna i mikrobiologia, 2010, Volume: 62, Issue:1 Topics: Adult; Aged; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Poland; Species Specificity	2010
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2011, Volume: 10, Issue:3 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2011
Comparison of the effects of subinhibitory concentrations of ciprofloxacin and colistin on the morphology of cardiolipin domains in Escherichia coli membranes. Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 4 Topics: Aminoacridines; Anti-Infective Agents; Cardiolipins; Cell Membrane; Ciprofloxacin; Colistin; Escherichia coli; Fluorescent Dyes; Microbial Sensitivity Tests; Microscopy, Fluorescence; Staining and Labeling	2012
In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Chemotherapy, 2011, Volume: 57, Issue:6 Topics: Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Steroids; Tobramycin	2011
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PloS one, 2012, Volume: 7, Issue:5 Topics: Aged; Ciprofloxacin; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Greece; Humans; Logistic Models; Male; Netilmicin; Retrospective Studies; Statistics, Nonparametric; Stenotrophomonas maltophilia; Treatment Outcome; Trimethoprim	2012
The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Anti-Bacterial Agents; Biofilms; Cations, Divalent; Chelating Agents; Ciprofloxacin; Colistin; Iron; Microbial Sensitivity Tests; Nitroquinolines; Plankton; Pseudomonas aeruginosa; Zinc	2012
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin	2014
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia. International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure	2014
In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:6 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2014
Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin	2015
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Clostridioides difficile; Colistin; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fever; Fluoroquinolones; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination	2015
Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis. The European respiratory journal, 2015, Volume: 46, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Chi-Square Distribution; Ciprofloxacin; Cohort Studies; Colistin; Confidence Intervals; Culture Media, Conditioned; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Young Adult	2015
Differential roles of antimicrobials in the acquisition of drug resistance through activation of the SOS response in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Mutagenesis; Rifampin; SOS Response, Genetics; Tetracyclines; Thienamycins	2015
Mucin Binding Reduces Colistin Antimicrobial Activity. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Culture Media; Daptomycin; Dialysis; Dialysis Solutions; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mucins; Polymyxin B; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus; Swine; Tobramycin	2015
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016, Volume: 254, Issue:2 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Imipenem; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Visual Acuity	2016
Protective role of E. coli outer membrane vesicles against antibiotics. Microbiological research, 2015, Volume: 181 Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Melitten; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Proteomics; Pseudomonas aeruginosa; Streptomycin; Trimethoprim	2015
Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3 Topics: Amides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Lung; Microscopy, Confocal; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines; Quorum Sensing; Respiratory Tract Infections; Tobramycin	2015
OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5 Topics: Animals; Biofilms; Ciprofloxacin; Colistin; Female; Interleukin-1alpha; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2016
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center. Haematologica, 2016, Volume: 101, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Central Venous Catheters; Ciprofloxacin; Cohort Studies; Colistin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucositis; Neutropenia; Retrospective Studies; Young Adult	2016
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline	2017
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:3 Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus. The Journal of hospital infection, 2018, Volume: 99, Issue:3 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cupriavidus; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Meropenem; Microbial Sensitivity Tests; Middle Aged; Shock, Septic; Treatment Outcome	2018
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin. Molecular pharmaceutics, 2018, 09-04, Volume: 15, Issue:9 Topics: Administration, Inhalation; Aerosols; Ciprofloxacin; Colistin; Drug Stability; Drug Synergism; Dry Powder Inhalers; Excipients; Leucine; Particle Size; X-Ray Diffraction	2018
Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa. Pharmaceutical research, 2018, Aug-09, Volume: 35, Issue:10 Topics: A549 Cells; Anti-Infective Agents; Cell Survival; Ciprofloxacin; Colistin; Drug Compounding; Drug Resistance, Bacterial; Drug Synergism; Humans; Phosphatidylcholines; Phospholipids; Pseudomonas aeruginosa; Surface Properties	2018
Evaluation of the ability of colistin, amoxicillin (components of Potencil Journal of veterinary pharmacology and therapeutics, 2019, Volume: 42, Issue:1 Topics: A549 Cells; Amoxicillin; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Ciprofloxacin; Colistin; Dose-Response Relationship, Drug; Drug Combinations; Enrofloxacin; Escherichia coli Infections; Humans; In Vitro Techniques; Lipopolysaccharides; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Vero Cells	2019
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa. International journal of pharmaceutics, 2018, Nov-15, Volume: 551, Issue:1-2 Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Phages; Tobramycin	2018
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin	2019
Bacteremia by Chryseobacterium oranimense, A Colistin-Resistant Gram-Negative Bacilli, in an Immunocompetent Pediatric Patient. The Pediatric infectious disease journal, 2019, Volume: 38, Issue:2 Topics: Anti-Bacterial Agents; Autistic Disorder; Bacteremia; Child; Chryseobacterium; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2019
Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling. Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:9 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Colistin; Drug Combinations; Drug Compounding; Dry Powder Inhalers; Feasibility Studies; Particle Size; Powders	2019
Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone. The Journal of hospital infection, 2020, Volume: 104, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model. International journal of pharmaceutics, 2019, Oct-05, Volume: 569 Topics: Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Colistin; Epithelial Cells; Humans; Liposomes; Lung; Pseudomonas aeruginosa; Pseudomonas Infections	2019
AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii. Microbial pathogenesis, 2020, Volume: 139 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colistin; DNA, Antisense; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Knockdown Techniques; Membrane Transport Proteins; Microbial Sensitivity Tests; Peptide Nucleic Acids; RNA, Messenger; Tetracycline	2020
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections. International journal of pharmaceutics, 2020, Feb-15, Volume: 575 Topics: A549 Cells; Administration, Inhalation; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Gram-Negative Bacterial Infections; Humans; Liposomes; Powders; Pseudomonas aeruginosa; Respiratory Tract Infections	2020
Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2020, 04-01, Volume: 75, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2020
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:10 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Calorimetry; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Netherlands; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Spain; Sweden	2020
Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study. European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:5 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Bone Diseases, Infectious; Ciprofloxacin; Cohort Studies; Colistin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Humans; Infusions, Intravenous; Joint Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections	2020
Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells. International journal of pharmaceutics, 2020, Aug-30, Volume: 586 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Cell Line; Chemistry, Pharmaceutical; Ciprofloxacin; Colistin; Drug Combinations; Drug Delivery Systems; Epithelial Cells; Humans; Liposomes; Lung; Powders	2020
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS biology, 2020, Volume: 18, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Furans; Gallium; Humans; Meropenem; Microbial Sensitivity Tests; Protein Biosynthesis; Pseudomonas aeruginosa; Quorum Sensing; Tobramycin; Virulence	2020
Rapid Killing and Biofilm Inhibition of Multidrug-Resistant Biomolecules, 2020, 08-14, Volume: 10, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Candida albicans; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gentamicins; Indoles; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Reactive Oxygen Species; Staphylococcus aureus	2020
Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cefotaxime; Ciprofloxacin; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence	2021
Co-delivery of ciprofloxacin and colistin using microcontainers for bacterial biofilm treatment. International journal of pharmaceutics, 2021, Apr-15, Volume: 599 Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Colistin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2021
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. Annals of clinical microbiology and antimicrobials, 2021, Mar-20, Volume: 20, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Thailand	2021
Isolation of persister cells within the biofilm and relative gene expression analysis of type II toxin/antitoxin system in Pseudomonas aeruginosa isolates in exponential and stationary phases. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Anti-Bacterial Agents; Antitoxins; Biofilms; Ciprofloxacin; Colistin; Gene Expression; Humans; Pseudomonas aeruginosa	2022
Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid. Scientific reports, 2022, 03-25, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Synergism; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics. Transboundary and emerging diseases, 2022, Volume: 69, Issue:5 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines	2022
Community-Acquired Uropathogenic MEDICC review, 2022, May-16, Volume: 24, Issue:2 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli	2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Journal of applied microbiology, 2022, Volume: 133, Issue:3 Topics: Anti-Bacterial Agents; Bacteriophages; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Evolutionary action of mutations reveals antimicrobial resistance genes in Escherichia coli. Nature communications, 2022, 06-09, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Mutation	2022
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran. International microbiology : the official journal of the Spanish Society for Microbiology, 2022, Volume: 25, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors	2022
The expression of type II TA system genes following persister cell formation in Pseudomonas aeruginosa isolates in the exponential and stationary phases. Archives of microbiology, 2022, Jul-04, Volume: 204, Issue:8 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Pseudomonas aeruginosa	2022
Future microbiology, 2022, Volume: 17 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Colistin; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated	2022
Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae. Acta microbiologica et immunologica Hungarica, 2022, Sep-16, Volume: 69, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colistin; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tobramycin	2022
Colistin conditioning surfaces combined with antimicrobial treatment to prevent ventilator-associated infections. Biofouling, 2022, Volume: 38, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Colistin; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Ventilators, Mechanical	2022
Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Colistin; Disinfectants; Drug Resistance, Multiple, Bacterial; Humans; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests	2022
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance. Current microbiology, 2022, Oct-15, Volume: 79, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2022
Prevalence of classes 1 and 2 integrons in multidrug-resistant Acinetobacter baumanni isolates recovered from some aquatic environment in South Africa. Scientific reports, 2022, 11-24, Volume: 12, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Enterobacteriaceae; Humans; Integrons; Male; Meropenem; Prevalence; South Africa	2022
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020. Indian journal of ophthalmology, 2022, Volume: 70, Issue:12 Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Longitudinal Studies; Moxifloxacin; Ofloxacin; Retrospective Studies	2022
The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia. Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin	2022
Electrical Broth Micro-Dilution for Rapid Antibiotic Resistance Testing. ACS sensors, 2023, 03-24, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Colistin; Drug Resistance, Microbial	2023
Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital. Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Genomics; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; United States	2023
Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates. PloS one, 2023, Volume: 18, Issue:11 Topics: Anti-Bacterial Agents; Antimicrobial Peptides; Ceftazidime; Chloramphenicol; Ciprofloxacin; Colistin; Drug Synergism; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Rifampin	2023